News

Investing.com -- Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug ...
Investing.com -- Sixt SE (ETR:SIXG) reported a mixed start to 2025, with first-quarter revenue coming ahead of expectations while earnings before tax (EBT) came short. The company’s shares fell nearly ...
BlackRock (NYSE: BLK)’s Chief Investment Officer for Fundamental Equities in EMEA Helen Jewell discussed the current market ...
Investing.com -- Shares of Western Digital Corp. (NASDAQ: WDC) climbed 4% after the company announced the authorization of a ...
Investing.com -- Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares tumbled 10.7% after the neuroscience-focused biopharmaceutical company reported first quarter earnings and announced a delay in ...
Despite Halozyme reporting generally positive first-quarter results, the stock was negatively impacted by the potential risk that its hyaluronidase combination products may face earlier price ...
Investing.com -- Raymond (NSE: RYMD) James has initiated coverage on Super Micro Computer (NASDAQ: SMCI) with an Outperform rating and a $41 price target, highlighting the company’s strong position in ...
Investing.com-- U.S. stock index futures traded in a mixed fashion Tuesday, as investors digested cooler-than-expected ...
Plug Power reported Q1 revenue of $133.7 million, up 11.1% YoY but below the analyst consensus of $138.41 million. Adjusted earnings per share came in at -$0.21, missing estimates by $0.02. Despite ...
Investing.com -- Shares of Regenxbio Inc . (NASDAQ: RGNX) climbed 7.2% in premarket trading after the company announced the U.S. Food and Drug Administration (FDA) has accepted for priority review its ...
Investing.com -- HSBC has downgraded Chevron (NYSE: CVX) from Buy to Hold, citing reduced valuation upside and a cut to ...
Despite the unfavorable trial results, iTeos Therapeutics has initiated a strategic review to maximize shareholder value. The company’s CEO, Michel Detheux, Ph.D., expressed disappointment over the ...